Therapies for castration‐resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines
A Mizokami, Y Kadono, Y Kitagawa… - … Journal of Urology, 2017 - Wiley Online Library
When advanced prostate cancer recurred during hormonal therapy and became the
castration‐resistant prostate cancer,“vintage hormonal therapy,” such as antiandrogen …
castration‐resistant prostate cancer,“vintage hormonal therapy,” such as antiandrogen …
Outcomes in studies regarding older patients with prostate cancer: A systematic review
Introduction Older patients are often deemed ineligible for clinical research, and many
frequently-used endpoints and outcome measures are not as relevant for older patients for …
frequently-used endpoints and outcome measures are not as relevant for older patients for …
[HTML][HTML] Dietary intake of 17α-ethinylestradiol promotes HCC progression in humanized male mice expressing sex hormone-binding globulin
SR Lee, SH Jeong, JH Heo, SL Jo, JW Ko… - International Journal of …, 2021 - mdpi.com
Hepatocellular carcinoma (HCC) is a male-oriented malignancy; its progression is affected
by sex hormones. 17α-ethinylestradiol (EE2) is a synthetic estrogen widely used as an oral …
by sex hormones. 17α-ethinylestradiol (EE2) is a synthetic estrogen widely used as an oral …
Therapeutic effect of ethinylestradiol in castration-resistant prostate cancer
T Nakano, Y Kadono, H Iwamoto, H Yaegashi… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: The best sequential treatment for castration-resistant prostate cancer
(CRPC) remains unclear. This study evaluated the therapeutic effects of ethinylestradiol (EE) …
(CRPC) remains unclear. This study evaluated the therapeutic effects of ethinylestradiol (EE) …
[HTML][HTML] Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review
HJTC Bennink, J Krijgh, JFM Egberts… - Endocrine …, 2022 - ec.bioscientifica.com
The purpose of androgen deprivation therapy (ADT) in prostate cancer (PCa), using
luteinizing hormone-releasing hormone agonists (LHRHa) or gonadotrophin releasing …
luteinizing hormone-releasing hormone agonists (LHRHa) or gonadotrophin releasing …
Role of estramustine phosphate and other estrogens for castration-resistant prostate cancer
T Inoue - Hormone Therapy and Castration Resistance of …, 2018 - Springer
The introduction of several expensive drugs, as abiraterone acetate and enzalutamide, and
expansion of indication of these new drugs for prostate cancer patients resulted in dramatic …
expansion of indication of these new drugs for prostate cancer patients resulted in dramatic …